Search Share Prices
AZN News - AstraZeneca’s presence in China boosted by Lynparza approval for ovarian cancer
Analysts said the prevalence of the BRCA-mutated ovarian cancer is higher in China and the approval will boost AstraZeneca’s already strong performance in the region AstraZeneca PLC’s (LON:AZN) ...
Global Chronic Kidney Disease Drugs Market Expected to Grow at a CAGR of 4.5% by 2027
This report also provides the existing competitive scenario of some of the key players of the global chronic kidney disease drugs market which includes company profiling of AstraZeneca (lon:AZN), ...
Premarket London: Boohoo's Record Black Friday; Cineworld Guides Lower
Boohoo’s next update is scheduled for Jan. 14. AstraZeneca (LON:AZN) said it has agreed to sell the U.S. and Canadian commercial rights for its off-patent drug Seroquel to Germany’s Cheplapharm ...
Psoriasis Drugs Market Growth at a CAGR 9.8%, Research Methodology, Growth Drivers, Recent Changes and Developments in the Market, 2019-2027
(lon:GSK), Johnson & Johnson Services, Inc. JNJ, -0.19%, Amgen Inc. AMGN, +0.08%, Celgene Corporation, AbbVie Inc. ABBV, -0.68%, Eli Lilly and Company LLY, -0.08%, AstraZeneca (lon:AZN) and Biocon ...
AstraZeneca cancer drug fast-tracked by the FDA
Anglo-Swedish drugs giant AstraZeneca PLC (LON:AZN) has been granted a priority review for a new drug’s use in a particularly aggressive and untreated form of lung cancer. Imfinzi, which is already ...